DSM: ‘Postbiotics deal will make us frontrunner in microbiome management' 19-Apr-2023 By Jane Byrne DSM is in exclusive negotiations with Adare Pharma Solutions in order to acquire Adare Biome, a pioneer in the development and manufacturing of postbiotics, for €275m (US$301.3m).